Indexed logomarkindexed.vc

KAHR

Biotech
Business Model
B2B
Website
kahrmedical.com
Last Round
Series AFeb 2020
Rounds
2

About

KAHR Medical develops bispecific fusion protein therapeutics targeting cancer and autoimmune diseases.

LinkedIn

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Series ASeries AFeb 2020

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Create Free Account

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies

Simtra BioPharma Solutions

Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...

Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Unknown·$3.2B·May 2026
inVentiv HealthAcquired

Biopharmaceutical services company

United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
WC
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech
Series G Plus·$2.4B·Nov 2021
AsymchemIPO

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020